Stéphane Bancel, CEO of Moderna
Moderna starts up third HIV vaccine trial, partnering with IAVI to study its shot in Africa
Earlier this year, Moderna and nonprofit research group IAVI (International AIDS Vaccine Initiative) announced that the first doses of an mRNA anti-HIV vaccine candidate had …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.